Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Takeda Pharmaceutical Co Ltd
NYSE:TAK
Takeda Pharmaceutical Co Ltd
NYSE:TAK
Price:
17.955
USD
-1.29%
Market Closed
Market Cap:
$56.9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Takeda Pharmaceutical Co Ltd
NYSE:TAK
|
JP |
|
S
|
Sasol Ltd
XMUN:SAOA
|
ZA |
Wall St Price Targets
TAK Price Forecast
Based on 18 analysts
Based on 18 analysts
+22% Upside
from
$17.955
today
Takeda Pharmaceutical Co Ltd (TAK)’s 12-month stock price forecast through October 2027 has a consensus target of $21.912, implying 22% upside. The forecast is based on price targets from 18 Wall Street analysts.
TAK Analyst Rating
Based on 4 analysts
Based on 4 analysts
Analysts rate TAK Strong buy, with 3 of 4 recommending Buy or Strong buy.
Takeda Pharmaceutical Co Ltd Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TAK's stock price target?
Price Target
21.912
USD
21.912
USD
According to Wall Street analysts, the average 1-year price target for TAK is 21.912 USD with a low forecast of 17.487 USD and a high forecast of 25.586 USD.
What is the Revenue forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
3%
3%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 3 years is 3%.
What is the Gross Profit forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
4%
4%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 3 years is 4%.
What is the Operating Income forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
-24%
-24%
Over the last 13 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 1 year is -24%.